학술논문

Hypoglycemic effect of Moringa oleifera leaf extract and its mechanism prediction based on network pharmacology
Document Type
article
Source
Journal of Future Foods, Vol 3, Iss 4, Pp 383-391 (2023)
Subject
Moringa oleifera leaves
Ultrahigh performance liquid chromatography-mass spectrometry
Hypoglycemia
Network pharmacology
PI3K-Akt signaling pathway
Food processing and manufacture
TP368-456
Language
English
ISSN
2772-5669
Abstract
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia, which poses a serious threat to human health. Moringa oleifera Lam is a medicinal and edible plant with various physiological functions. However, its main hypoglycemic components and mechanisms are still unclear. In this study, network pharmacology and bioinformatics were used to analyze the potential bioactive substances of M. oleifera leaf extract (MOLE) and its hypoglycemic mechanism. Studies have shown that MOLE has the effect of increasing glucose consumption in insulin resistant-HepG2 cells. MOLE was found to contain 975 compounds by ultrahigh performance liquid chromatography-mass spectrometry (UHPLC-MS). Network pharmacology analysis indicated that the main active component was robinetin and the identified core genes were AKT1 and GAPDH. KEGG pathway enrichment analysis showed that the hypoglycemic effect of MOLE may be closely related to the PI3K-Akt signaling pathway. This study revealed the possible active components and mechanisms of action of M. oleifera for hypoglycemia, laying the theoretical foundation for subsequent studies.